相关实验视频

Updated: Jun 10, 2025

Semi-automatic PD-L1 Characterization and Enumeration of Circulating Tumor Cells from Non-small Cell Lung Cancer Patients by Immunofluorescence
10:29

Semi-automatic PD-L1 Characterization and Enumeration of Circulating Tumor Cells from Non-small Cell Lung Cancer Patients by Immunofluorescence

Published on: August 14, 2019

10.5K

一个基于瘤角化和免疫透的方案,用于抗PD-1以及晚期平细胞肺癌中化疗反应

Minlin Jiang1, Jiya Sun2, Congli Hu1

  • 1Department of Medical Oncology, Shanghai Pulmonary Hospital, Tongji University Medical School Cancer Institute, Tongji University School of Medicine, Shanghai 200433, China; Medical School, Tongji University, Shanghai 200433, China.

Med (New York, N.Y.)
|October 12, 2024
PubMed
概括

在状细胞肺癌 (LUSC) 中确定了抗PD-1加化疗的生物标志物. 一个新的分类系统 (LICC) 基于瘤免疫透和角化预测治疗反应.

关键词:
CD56 (((明亮的) NK细胞在PD-1中使用PD-1.在RNA-seqqq.翻译给患者使用.激活的CD8 (((+) T细胞生物标志物生物标志物角化 (Cornification) 是指角化的一种形式.免疫疗法 免疫疗法一个单细胞RNA-seqq.状细胞肺癌是一种肺癌.瘤微环境是一个微环境.

更多相关视频

Intramucosal Inoculation of Squamous Cell Carcinoma Cells in Mice for Tumor Immune Profiling and Treatment Response Assessment07:29

Intramucosal Inoculation of Squamous Cell Carcinoma Cells in Mice for Tumor Immune Profiling and Treatment Response Assessment

Published on: April 22, 2019

11.4K
Orthotopic Transplantation of Syngeneic Lung Adenocarcinoma Cells to Study PD-L1 Expression06:03

Orthotopic Transplantation of Syngeneic Lung Adenocarcinoma Cells to Study PD-L1 Expression

Published on: January 19, 2019

16.9K

相关概念视频

Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
488